CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 4 Open-market buy President bought 15,000 shares at an average $0.06 ($891)
- 4 Open-market buy President bought 15,000 shares at an average $0.06 ($961)
- 4 Open-market buy President bought 22,050 shares at an average $0.06 ($1,340)
- 4 Open-market buy President bought 29,050 shares at an average $0.06 ($1,743)
- 4 Open-market buy President bought 27,000 shares at an average $0.07 ($1,812)
- 4 Open-market buy President bought 14,000 shares at an average $0.06 ($868)
- 4 Open-market buy President bought 30,000 shares at an average $0.06 ($1,798)
- 4 Open-market buy President bought 29,000 shares at an average $0.06 ($1,797)
- 4 Open-market buy President bought 23,000 shares at an average $0.06 ($1,278)
- 4 Open-market buy President bought 28,300 shares at an average $0.05 ($1,464)
- 4 Open-market buy President bought 30,000 shares at an average $0.06 ($1,687)
- 4 Open-market buy President bought 18,000 shares at an average $0.06 ($1,075)
- 4 Open-market buy President bought 12,000 shares at an average $0.06 ($741)
- 4 Open-market buy President bought 30,000 shares at an average $0.06 ($1,874)
- 4 Open-market buy President bought 30,000 shares at an average $0.06 ($1,818)
- 4 Open-market buy President bought 33,000 shares at an average $0.06 ($2,017)
- 4 Open-market buy President bought 8,000 shares at an average $0.06 ($503)
- 4 Open-market buy President bought 30,000 shares at an average $0.07 ($2,027)
- 10-Q Report Quarterly Report
- 4 Open-market buy President bought 13,000 shares at an average $0.07 ($854)
Page 17 of 26 · 502 filings